Expanding Capabilities to Support Early and Late-Stage Drug Development with Comprehensive Manufacturing SolutionsElkridge, Maryland--(Newsfile ...

Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

Researchers describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease ...

Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...

Avera participates in numerous clinical trials, including ones that are Phase 1. In this Avera Medical Minute, we share what ...